Susquehanna International Group, LLP Enanta Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 16, 2023	BUY	$38.82 - $54.59 $322,206 - $453,097	8,300 New	8,300 $335,000
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $318,714 - $470,382	-6,600 Reduced 54.55%	5,500 $285,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $335,544 - $676,984	8,800 Added 266.67%	12,100 $572,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $89,696 - $118,576	-1,600 Reduced 32.65%	3,300 $235,000
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $734,318 - $1.19 Million	-12,200 Reduced 71.35%	4,900 $366,000
Q2 2021 Aug 11, 2021	SELL	$43.76 - $53.11 $1.05 Million - $1.27 Million	-23,900 Reduced 58.29%	17,100 $753,000
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $129,239 - $170,345	-3,100 Reduced 7.03%	41,000 $2.02 Million
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $1.32 Million - $1.52 Million	32,100 Added 267.5%	44,100 $1.86 Million
Q3 2020 Nov 16, 2020	BUY	$43.36 - $53.53 $34,688 - $42,824	800 Added 7.14%	12,000 $549,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $836,576 - $1.29 Million	-20,800 Reduced 65.0%	11,200 $576,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $2.61 Million - $3 Million	-45,100 Reduced 58.5%	32,000 $1.98 Million
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $835,112 - $1.23 Million	-13,900 Reduced 15.27%	77,100 $4.63 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $4.28 Million - $5.13 Million	52,700 Added 137.6%	91,000 $7.68 Million
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $131,252 - $200,754	1,900 Added 5.22%	38,300 $3.66 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $2.04 Million - $2.64 Million	31,200 Added 600.0%	36,400 $2.58 Million
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $675,134 - $998,323	-7,900 Reduced 60.31%	5,200 $444,000
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $671,170 - $988,182	8,200 Added 167.35%	13,100 $1.52 Million
Q1 2018 May 15, 2018	SELL	$57.91 - $92.15 $243,222 - $387,030	-4,200 Reduced 46.15%	4,900 $396,000
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $344,980 - $425,880	9,100	9,100 $426,000

Others Institutions Holding ENTA

# of Institutions

107

Shares Held

18.3M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$15.1 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$14.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$13.2 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$10.7 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.22M
Shares

$8.72 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $148M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account